Glecaprevir
Especificaciones
1365970-03-1Número CAS
(1R,14E,18R,22R,26S,29S)-26-tert-butyl-N-[(1R,2R)-2-(difluoromethyl)-1-[(1-methylcyclopropyl)sulfonylcarbamoyl]cyclopropyl]-13,13-difluoro-24,27-dioxo-2,17,23-trioxa-4,11,25,28-tetrazapentacyclo[26.2.1.03,12.05,10.018,22]hentriaconta-3,5,7,9,11,14-hexaeneNombre IUPAC
C38H46F4N6O9SFórmula química
838.9 g/molPeso molecular
Glecaprevir; 1365970-03-1; ABT-493; Maviret; K6BUU8J72P; A-1282576.0; A-1282576; A-12825760; DTXSID901027945; (1R,14E,18R,22R,26S,29S)-26-tert-butyl-N-[(1R,2R)-2-(difluoromethyl)-1-[(1-methylcyclopropyl)sulfonylcarbamoyl]cyclopropyl]-13,13-difluoro-24,27-dioxo-2,17,23-trioxa-4,11,25,28-tetrazapentacyclo[26.2.1.03,12.05,10.018,22]hentriaconta-3,5,7,9,11,14-hexaene-29-carboxamide; glecaprevirum; (1R,14E,18R,22R,26S,29S)-26-tert-butyl-N-((1R,2R)-2-(difluoromethyl)-1-((1-methylcyclopropyl)sulfonylcarbamoyl)cyclopropyl)-13,13-difluoro-24,27-dioxo-2,17,23-trioxa-4,11,25,28-tetrazapentacyclo(26.2.1.03,12.05,10.018,22)hentriaconta-3,5,7,9,11,14-hexaene-29-carboxamide; RefChem:663069; DTXCID101513512; Glecaprevir [USAN]; (33R,35S,91R,92R,5S,E)-5-(tert-butyl)-N-((1R,2R)-2-(difluoromethyl)-1-(((1-methylcyclopropyl)sulfonyl)carbamoyl)cyclopropyl)-14,14-difluoro-4,7-dioxo-2,8,10-trioxa-6-aza-1(2,3)-quinoxalina-3(3,1)-pyrrolidina-9(1,2)-cyclopentanacyclotetradecaphan-12-ene-35-carboxamide; UNII-K6BUU8J72P; ABT 493; ABT 493; (3aR,7S,10S,12R,21E,24aR)-7-tert-Butyl-N-((1R,2R)-2-(difluoromethyl)-1-((1-methylcyclopropane-1-sulfonyl)carbamoyl)cyclopropyl)-20,20-difluoro-5,8-dioxo-2,3,3a,5,6,7,8,11,12,20,23,24a-dodecahydro-1H,10H-9,12-methanocyclopenta(18,19)(1,10,17,3,6)trioxadiazacyclononadecino(11,12-b)quinoxaline-10-carboxamide;; O31; 1365970-03-1 (free); GLECAPREVIR [MI]; GLECAPREVIR [INN]; Glecaprevir (USAN/INN); ABT-493(Glecaprevir)?; GLECAPREVIR [WHO-DD]; SCHEMBL883097; ABT493; orb1302067; CHEMBL3545363; SCHEMBL29368105; GTPL11267; GLECAPREVIR [ORANGE BOOK]; (1R,14Z,18R,22R,26S,29S)-26-tert-butyl-N-[(1R,2R)-2-(difluoromethyl)-1-[(1-methylcyclopropyl)sulfonylcarbamoyl]cyclopropyl]-13,13-difluoro-24,27-dioxo-2,17,23-trioxa-4,11,25,28-tetrazapentacyclo[26.2.1.03,12.05,10.018,22]hentriaconta-3,5,7,9,11,14-hexaene-29-carboxamide; EX-A1940; MAVYRET COMPONENT GLECAPREVIR; BDBM50573891; s5720; CS-8098; DB13879; (3aR,7S,10S,12R,21E,24aR)-7-tert-butyl-N-{(1R,2R)-2(difluoromethyl)-1-[(1-methylcyclopropane-1-sulfonyl)carbamoyl]cyclopropyl}-20,20-difluoro5,8-dioxo-2,3,3a,5,6,7,8,11,12,20,23,24a-dodecahydro-1H,10H-9,12methanocyclopenta[18,19][1,10,17,3,6]trioxadiazacyclononadecino[11,12-b]quinoxaline-10carboxamide; AC-33419; HY-17634; NS00133774; D10814; D84121; F836983; 3,6]trioxadiazacyclononadecino[11,12-b]quinoxaline-10-carboxamide; (1R,2R)-N-[[[(1R,2R)-2-[[4,4-difluoro-4-(3-hydroxy-2-quinoxalinyl)-2-buten-1-yl]oxy]cyclopentyl]oxy]carbonyl]-3-methyl-L-valyl-(4R)-4-hydroxy-L-prolyl-1-amino-2-(difluoromethyl)-N-[(1-methylcyclopropyl)sulfonyl]-cyclopropanecarboxamide cyclic (1 inverted exclamation marku2)-ether; (3aR,7S,10S,12R,21E,24aR)-7-tert-butyl-N-((1R,2R)-2-(difluoromethyl)-1-((1-methylcyclopropane-1-sulfonyl)carbamoyl)cyclopropyl)-20,20-difluoro-5,8-dioxo-2,3,3a,5,6,7,8,11,12,20,23,24a-dodecahydro-1H,10H-9,12-methanocyclopenta(18,19)(1,10,17,3,6)trioxadiazacyclononadecino(11,12-b)quinoxaline-10-carboxamide; (3aR,7S,10S,12R,21E,24aR)-7-tert-butyl-N-[(1R,2R)-2-(difluoromethyl)-1-{[(1-methylcyclopropyl)sulfonyl]carbamoyl}cyclop; (3aR,7S,10S,12R,21E,24aR)-7-tert-butyl-N-[(1R,2R)-2-(difluoromethyl)-1-{[(1-methylcyclopropyl)sulfonyl]carbamoyl}cyclopropyl]-20,20-difluoro-5,8-dioxo-2,3,3a,5,6,7,8,11,12,20,23,24a-dodecahydro-1H,10H-9,12-methanocyclopenta[18,19][1,10,17,3,6]trioxadiazacyclononadecino[11,12-b]quinoxaline-10-carboxamide; (3aR,7S,10S,12R,21E,24aR)-7-tert-butyl-N-{(1R,2R)-2- (difluoromethyl)-1-[(1-methylcyclopropane-1-sulfonyl)carbamoyl]cyclopropyl}-20,20-difluoro- 5,8-dioxo-2,3,3a,5,6,7,8,11,12,20,23,24a-dodecahydro-1H,10H-9,12- methanocyclopenta[18,19][1,10,17,3,6]trioxadiazacyclononadecino[11,12-b]quinoxaline-10- carboxamide hydrate; Cyclopropanecarboxamide, N-((((1R,2R)-2-((4,4-difluoro-4-(3-hydroxy-2-quinoxalinyl)-2-buten-1-yl)oxy)cyclopentyl)oxy)carbonyl)-3-methyl-L-valyl-(4R)-4-hydroxy-L-prolyl-1-amino-2-(difluoromethyl)-N-((1-methylcyclopropyl)sulfonyl)-, cyclic (1->2)-ether, (1R,2R)-; ropyl]-20,20-difluoro-5,8-dioxo-2,3,3a,5,6,7,8,11,12,20,23,24a-dodecahydro-1H,10H-9,12-methanocyclopenta[18,19][1,10,17,Sinónimos
Productos que contienen Glecaprevir
마비렛정マヴィレット配合錠マヴィレット配合顆粒小児用MAVIRET 50 MG/20 MG GRANULOS RECUBIERTOS EN SOBREMAVIRET 100 MG/40 MG COMPRIMIDOS RECUBIERTOS CON PELICULAMAVIRET 50 mg/20 mg, granulés enrobés en sachetMAVIRET 100 mg/40 mg, comprimé pelliculéGlecaprevirGlecaprevirGLECAPREVIRGlecaprevirGlecaprevir
Página 1 de 2
Empresas que venden Glecaprevir
AD
Abbvie Deutschland GmbH & Co. KGGermany
HR
Hangzhou Royall Import & Export Co.,LtdChinaJM
Jiangsu Magic Biotechnology Co., LtdChinaSL
Shanghai Life Bio-Tech Co.,LTDChina한국
한국애브비(주)Republic of Koreaアッ
アッヴィ合同会社JapanBS
BEIJING SJAR TECHNOLOGY DEVELOPMENT CO., LTD.ChinaAC
AFINE CHEMICALS LIMITED